COLL
NASDAQ
$35.54
Collegium Pharmaceutical Inc (COLL)
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
Sector:
Healthcare
Buy
Target: $53.60 (+50.82%)
Market Cap
$1.19B
FCF 5Y CAGR
+23.23%
Forward P/E
4.86
P/E Ratio
40.29
Price Chart
Valuation
Market Cap$1.19B
P/E40.29
Forward P/E4.86
P/S1.43
P/B3.62
Profitability
Total Revenue (TTM)$796M
Gross Profit (TTM)$710M
EBITDA$192M
Profit Margin7.5%
Operating Margin16%
EPS$0.91
Financial Health
Free Cash Flow Yield27.72%
Growth & Risk
EPS 5Y CAGR-5.45%
Revenue 5Y CAGR+19.91%
FCF 5Y CAGR+23.23%
Beta (5Y)0.50
Sharpe Ratio0.35